ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (EU)
    • Education
    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement
    • Training
    • FAQ

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • Leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Medical Professionals
Distributor Inquiries
Acarix Acarix
Book a demo
Menu

Rights Issue/Warrant Program

Rights Issue/Warrant Program

2024

CEO LETTER 2024 TO3
ACARIX APPLICATION WARRANTS SERIES 2024 U2 TO3
Villkor för teckningsoptioner i Acarix AB serie 2024U1
Acarix anmälan teckningsoptioner serie 2024 U1_240304
March 6 2024 Press Release

2023

Application form for subscription of shares without the use of subscription rights Acarix
Application form for subscription of shares without the use of subscription rights AcarixSpecial application form – for subscription of shares using subscription rights Acarix
Acarix_Årsredovisning 2022
Bolagsordning
Anmälningssedel Acarix AB
Acarix AB – Prospekt.
Acarix-Q2-2023-SV
Acarix_Årsredovisning_2021_SV
Acarix AB – Registreringsbevis
Anmälningssedel Acarix AB
Bilaga 1a – Styrelseredogörelse 13 kap 6 § och 14 kap 8 § ABL
Proposal on preferential rights issue of units EGM 2023
Yttrande_PwC-signed

2022

Prospekt
Tillaggsprospekt
Bolagsordning
Registreringsbevis
Arsredovisning 2020
Arsredovisning 2021
Delarsrapport_Jan-Sep_2022
Anmalningssedel_UF_Acarix
Subscription form_Acarix

Contact Us

Please visit our contact page to get in touch.

Go to contact page

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (EU)
  • Clinical Studies
  • Downloads (US)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • X (twitter)

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.